Search results for "Predictive value of test"

showing 10 items of 854 documents

Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated ampli…

2007

Monitoring of HCV-RNA in blood during antiviral therapy is performed mostly by commercially available reverse transcription polymerase chain reaction-based (RT-PCR) assays, with a lower detection limit of 30-50 IU/mL of HCV-RNA. Use of different tests in the pivotal trials of combination therapy has generated some discordance, in terms of predictive value of the early virological response (EVR). To evaluate whether the use of a more sensitive test, as a qualitative assay based on transcription mediated amplification (TMA) with a lower detection limit of 5-10 IU/mL of HCV-RNA, may obtain a better prediction of EVR and of the ultimate virological outcome, we retrospectively evaluated serial s…

Malemedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/09 - Medicina InternaCombination therapyGenotypeTranscription GeneticTranscription-mediated amplificationHepacivirusAlpha interferonHepacivirusInterferon alpha-2GastroenterologyAntiviral AgentsSensitivity and Specificityantiviral therapy EVR HCV chronic hepatitis HCV-RNA RT-PCR TMAPolyethylene Glycolschemistry.chemical_compoundInterferonPredictive Value of TestsVirologyInternal medicineRibavirinmedicineHumansRetrospective StudiesSettore MED/12 - GastroenterologiaHepatologybiologybusiness.industryReverse Transcriptase Polymerase Chain ReactionRibavirinInterferon-alphaNucleic acid amplification techniqueHepatitis C Chronicbiology.organism_classificationVirologydigestive system diseasesRecombinant ProteinsInfectious DiseasesReal-time polymerase chain reactionTreatment OutcomechemistryRNA ViralDrug Therapy CombinationFemalebusinessNucleic Acid Amplification Techniquesmedicine.drug
researchProduct

Heart rate variability in sick sinus syndrome: does it have a diagnostic role?

2019

BACKGROUND: Hypothesis of our study was that the irregular rhythm of sick sinus syndrome (SSS) was characterized by an augmented HRV. Objective was to assess whether SSS patients had a typical HRV profile. METHODS: We screened all 1947 consecutive Holter ECGs performed in our Units of Vascular Medicine and Internal Medicine and Cardioangiology at the University of Palermo (Italy) from April 2010 to September 2014. Among these, we selected 30 patients with ECG criteria of SSS. They were compared to 30 patients without SSS matched for age, sex and comorbidities. RESULTS: The SSS group had a lower mean heart rate (HR) (P=0.003), and a longer mean NN max-min longer (P<0.0005) compared to con…

Malemedicine.medical_specialtySettore MED/09 - Medicina Interna030204 cardiovascular system & hematologySick sinus syndrome03 medical and health sciences0302 clinical medicineHeart RatePredictive Value of TestsInternal medicineHeart ratemedicineHeart rate variabilityHumans030212 general & internal medicineAgedRetrospective StudiesAged 80 and overSick Sinus Syndromemedicine.diagnostic_testbusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseSSS*ItalyHolter ECG HR SDNNi HRVPredictive value of testsCase-Control StudiesAmbulatoryCardiologyElectrocardiography AmbulatoryFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyMinerva cardioangiologica
researchProduct

The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis.

2009

Recent guidelines published by the joint European Society of Hypertension/European Society of Cardiology have suggested the inclusion of C-reactive protein (CRP) in the standard assessment of cardiovascular risk in hypertensive patients, but little data is available on the role of CRP in patients with carotid lesions. We studied in 472 subjects, 236 with and 236 without hypertension, gender- and age-matched, with and without early stages of atherosclerosis (e.g. those with asymptomatic intima-media thickness >0.9 mm), the influence of all the other traditional cardiovascular risk factors (e.g. older age, male gender, obesity, diabetes, smoking habit, family history of coronary artery diseas…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaInflammationAsymptomaticCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicineDiabetes mellitusCRP Hypertension Subclinical Atherosclerosis atherosclerosisInternal MedicinemedicineHumansIn patientFamily historyAgedbiologybusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseC-reactive protein hypertension inflammation event atherosclerosisAtherosclerosisObesitySettore MED/11 - Malattie Dell'Apparato CardiovascolareCerebrovascular DisordersC-Reactive ProteinCase-Control StudiesHypertensionCardiologybiology.proteinFemalemedicine.symptombusinessBiomarkersFollow-Up StudiesInternal medicine journal
researchProduct

Sentinel lymph node biopsy in malignant melanoma of the head and neck

2018

Abstract Background The aim of this retrospective study was to investigate sentinel lymph node biopsy in patients with head and neck melanoma. Materials and methods Patients who underwent SLNB between 2010 and 2016 were comprised. Epidemiological, radiological, and surgical data were collected and compared to histological findings. Patients who underwent primary complete lymph node dissection were excluded. Results 74 patients underwent SLNB during this period. The most common tumor localizations were the cheek (20.4%) and ears (20.4%). Overall, 256 sentinel lymph nodes (SLN) were detected and removed, most frequently in Robbins-levels IIA and IIB as well as in the surrounding of the paroti…

Malemedicine.medical_specialtySkin NeoplasmsSentinel lymph nodeMetastasis030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePredictive Value of TestsBiopsyHumansParotid GlandMedicineMelanomaLymph nodeAgedNeoplasm StagingRetrospective Studiesmedicine.diagnostic_testSentinel Lymph Node Biopsybusiness.industryMelanomaEarMiddle AgedPrognosismedicine.diseaseParotid glandCheekLymphatic systemmedicine.anatomical_structureOtorhinolaryngologyHead and Neck NeoplasmsLymphatic Metastasis030220 oncology & carcinogenesisLymph Node ExcisionFemaleSurgeryLymph NodesLymphRadiologyNeoplasm Recurrence LocalOral SurgerybusinessHeadNeckJournal of Cranio-Maxillofacial Surgery
researchProduct

Three-Dimensional Analysis of Component Stability of the Nellix Endovascular Aneurysm Sealing System After Treatment of Infrarenal Abdominal Aortic A…

2016

Purpose: To assess short-term stability and conformational changes of the Nellix EndoVascular Aneurysm Sealing (EVAS) System using 3-dimensional (3D) analysis. Methods: Postoperative computed tomography (CT) scans obtained at 0, 3, and 12 months in 24 patients (mean age 75±7 years; 22 men) who underwent EVAS between December 2013 and December 2014 for intact abdominal aortic aneurysm (within the instructions for use) were evaluated for stent-graft deviation in multiple planes using dedicated 3D analysis software. In addition, 2D analysis using an anatomically fixed reference landmark was performed to assess craniocaudal migration. Clinical and follow-up data of the patients were recorded a…

Malemedicine.medical_specialtyThree dimensional analysisTime FactorsEndoleak3d analysisComputed tomography030204 cardiovascular system & hematologyProsthesis DesignAortography030218 nuclear medicine & medical imagingBlood Vessel Prosthesis Implantation03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineAneurysmForeign-Body MigrationPredictive Value of TestsHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesComputed tomography angiographyAged 80 and overmedicine.diagnostic_testbusiness.industryEndovascular ProceduresMean ageMiddle Agedmedicine.diseaseAbdominal aortic aneurysmBlood Vessel ProsthesisTreatment OutcomeRadiographic Image Interpretation Computer-AssistedFemaleStentsSurgeryRadiologyCardiology and Cardiovascular MedicinebusinessAfter treatmentAortic Aneurysm AbdominalJournal of Endovascular Therapy
researchProduct

Diagnosis of silent coronary ischemia with selective coronary revascularization might improve 2-year survival of patients with critical limb-threaten…

2021

Abstract Background Patients with critical limb-threatening ischemia (CLTI) have had poor long-term survival after lower extremity revascularization owing to coexistent coronary artery disease. A new cardiac diagnostic test, coronary computed tomography-derived fractional flow reserve (FFRCT), can identify patients with ischemia-producing coronary stenosis who might benefit from coronary revascularization. We sought to determine whether the diagnosis of silent coronary ischemia before limb salvage surgery with selective postoperative coronary revascularization can reduce the incidence of adverse cardiac events and improve the survival of patients with CLTI compared with standard care. Metho…

Malemedicine.medical_specialtyTime FactorsComputed Tomography AngiographyCritical IllnessIschemiaFractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyRisk AssessmentCoronary artery disease03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicineIschemiaPredictive Value of TestsRisk FactorsInternal medicinemedicineMyocardial RevascularizationHumans030212 general & internal medicineMyocardial infarctionProspective StudiesStrokeAgedbusiness.industryHazard ratioCoronary ischemiaMiddle Agedmedicine.diseaseLimb SalvageFractional Flow Reserve MyocardialStenosisTreatment OutcomeCase-Control StudiesAsymptomatic DiseasesCardiologySurgeryFemaleCardiology and Cardiovascular MedicinebusinessJournal of vascular surgery
researchProduct

Pre-operative Diagnosis of Silent Coronary Ischaemia May Reduce Post-operative Death and Myocardial Infarction and Improve Survival of Patients Under…

2019

Objective Patients undergoing peripheral vascular surgery have increased risk of death and myocardial infarction (MI), which may be due to unsuspected (silent) coronary ischaemia. The aim was to determine whether pre-operative diagnosis of silent ischaemia using coronary computed tomography (CT) derived fractional flow reserve (FFRCT) can facilitate multidisciplinary care to reduce post-operative death and MI, and improve survival. Methods This was a single centre prospective study with historic controls. Patients with no cardiac symptoms undergoing lower extremity surgical revascularisation with pre-operative coronary CTA-FFRCT testing were compared with historic controls with standard pre…

Malemedicine.medical_specialtyTime FactorsComputed Tomography Angiographymedicine.medical_treatmentMyocardial InfarctionFractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematology030230 surgeryCoronary AngiographyRisk Assessment03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicinemedicineHumansMyocardial infarctionProspective StudiesProspective cohort studyAgedmedicine.diagnostic_testbusiness.industryCoronary StenosisPercutaneous coronary interventionVascular surgeryMiddle Agedmedicine.diseaseFractional Flow Reserve MyocardialStenosismedicine.anatomical_structureLower ExtremityCase-Control StudiesAngiographyAsymptomatic DiseasesCardiologySurgeryFemaleCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresArteryEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
researchProduct

Use of covered chimney stents for pararenal aortic pathologies is safe and feasible with excellent patency and low incidence of endoleaks.

2012

Background To present the clinical experience of consecutive series with use of balloon-expandable and self-expanding chimney endografts (balloon-expandable covered stent group [BECS] vs self-expanding covered stent group [SECS]) in the endovascular treatment of challenging aortic pathologies requiring renal and/or visceral revascularization. Methods Between January 2009 and May 2011, data for 37 high-risk patients from one center and 35 patients from another institution, with pararenal aortic pathologies treated by the chimney endovascular technique, were prospectively collected. The chimney-graft technique is based on the deployment of a covered or bare-metal stent parallel to the aortic …

Malemedicine.medical_specialtyTime FactorsEndoleakmedicine.medical_treatmentEVAR aneurysm chimney periscopesAortic Diseases610 Medicine & healthKaplan-Meier EstimateRevascularizationBalloonProsthesis DesignSettore MED/22 - Chirurgia VascolareAortographyRisk Assessment2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationPredictive Value of TestsRisk FactorsAngioplastyGermanymedicineHumansVascular PatencyComputed tomography angiographyAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryStentPerioperativemedicine.disease10020 Clinic for Cardiac Surgery2746 SurgerySurgeryBlood Vessel ProsthesisStenosisTreatment OutcomeCuffSurgeryFemaleStentsRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedAngioplasty BalloonSwitzerlandJournal of vascular surgery
researchProduct

Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Pat…

2020

Background Risk stratification among patients with coronary artery disease ( CAD ) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase‐type plasminogen activator receptor (su PAR ) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD . Methods and Results Plasma levels of su PAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography—including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris. Cardiovascular death and/or nonfatal myocardial infarction were defined as main o…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial InfarctionRenal functionCoronary Artery Disease030204 cardiovascular system & hematologyKidneyRisk AssessmentReceptors Urokinase Plasminogen Activatorsoluble urokinase‐type plasminogen activator receptorTroponin CCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineSecondary PreventionmedicineHumanscardiovascular diseasesMyocardial infarctionReceptorAgedOriginal Research030304 developmental biologyUrokinase0303 health sciencesbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinC-Reactive ProteinHeart Disease Risk FactorsCardiologybiomarkerBiomarker (medicine)FemaleKidney DiseasesCardiology and Cardiovascular MedicinebusinessPlasminogen activatorBiomarkersGlomerular Filtration Ratemedicine.drugJournal of the American Heart Association
researchProduct

Prognostic value of troponin I in atrial fibrillation

2021

To evaluate whether circulating cardiac troponin I (cTnI) levels are associated with worst outcomes in patients with atrial fibrillation (AF).Consecutive patients visiting the emergency room (ER) with a new episode of a previously diagnosed AF or a new diagnosis of AF during ER admission between January 1st, 2010 and December 31st, 2015, were enrolled in the study (n = 2617). After applying exclusion criteria and eliminating repeated episodes, 2013 patients were finally included. Of these, 1080 patients with at least one cTnI measurement in the ER were selected and classified into 4 groups according to cTnI quartiles: Q1 (n = 147) cTnI10 ng/L (Group 1); Q2 (n = 254): 10-19 ng/L (Group 2); Q…

Malemedicine.medical_specialtyTime FactorsHeart failureComorbidity030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicineTroponin ImedicineClinical endpointAtrial fibrillation Emergency Heart failure Mortality TroponinsTroponinsHumans030212 general & internal medicineRisk factorMortalityAdverse effectAgedRetrospective StudiesAged 80 and overbiologybusiness.industryTroponin IAtrial fibrillationMiddle AgedPrognosismedicine.diseaseTroponinAtrial fibrillationQuartileHeart failureEmergencybiology.proteinFemaleEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct